Cargando…
Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope
Angiogenesis inhibition has been proposed as a general strategy to fight cancer. However, in spite of the promising preclinical results, a first generation of antiangiogenic compounds yielded poor results in clinical trials. Conceptual errors and mistakes in the design of trials and in the definitio...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922346/ https://www.ncbi.nlm.nih.gov/pubmed/17635633 http://dx.doi.org/10.1111/j.1582-4934.2007.00056.x |